Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) had its price target decreased by investment analysts at Craig Hallum from $2.00 to $1.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “hold” rating on the medical research company’s stock. Craig Hallum’s price objective suggests a potential […]
Analysts at StockNews.com assumed coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) in a report issued on Wednesday. The firm set a “hold” rating on the medical research company’s stock. Accelerate Diagnostics Trading Down 2.0 % Accelerate Diagnostics stock opened at $0.99 on Wednesday. The firm’s 50 day simple moving average is […]
Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.26) EPS for the quarter, Yahoo Finance reports. The business had revenue of $1.04 million for the quarter. Lucid Diagnostics had a negative net margin of 2,169.07% and a negative return on equity of 8,334.14%. During the same […]
/PRNewswire/ -- The "North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test...
Co-Diagnostics (NASDAQ:CODX – Get Free Report) will release its earnings data after the market closes on Thursday, March 14th. Analysts expect Co-Diagnostics to post earnings of ($0.20) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. Co-Diagnostics Price Performance CODX stock opened […]